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Period and Cohort Factors
in the Incidence of Malignant Melanoma
in the State of Connecticut
by James J. Collins* and Nancy Devinet
The reasons for the increase in both incidence and mortality from malignant melanoma are not clear at
this time, although there is an indication of a "generation effect" in the increasing frequency of the
disease. The application of an age-period-cohort model to incidence data on malignant melanoma for the
State of Connecticut indicate that, unlike mortality, the increase is almost entirely related to period
factors. Twoexplanations areprovidedtoexplainthispatternofperiodfactorincrease. First, the increasein
incidence could be artifically produced by better and earlier diagnosis. Second, a decrease in ozone level in
the atmosphere may be responsible for the increase.
The incidence of malignant melanoma has been in-
creasing in Connecticut since at least 1935 (1) and has
doubled in the U.S. in the last ten years (2), while
mortality from this cancer has been increasing since at
least 1950 (3). Figure 1 presents age standardized rates
for malignant melanoma incidence and total skin cancer
mortality for U.S. data arranged by calendar year. The
reason for this increase in rates is not clear at this time.
Cohort analyses of both incidence and mortality from
malignant melanoma suggest the presence of a "gen-
eration effect" inthe increasingfrequency ofthe disease
in western populations (3-5). More recently, two studies
have considered both calendar year (period effect) and
year ofbirth (cohort effect) simultaneously in the same
model (6,7). These period-cohort analyses conclude, as
did the cohort analyses, that the major factor behind
the current increase in the mortality from malignant
melanoma was the systematic increase in the rates for
later birth cohorts. These studies, however, focused
only on mortality. The purpose of this paper is to
perform an age-period-cohort analysis onincidence data
for the state of Connecticut to determine if the cohort
hypothesis is also appropriate for incidence data.
Materials and Methods
Age-specific incidence rates in 5-year age groups for
5-year periods for malignant melanoma were provided
by the Connecticut Tumor Registry. The years covered
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by the registry are 1935-1939 to 1970-1974. Only the
age groups 20 to 24 to 80 to 84 are included in the
analysis. Incidence for ages below age 20 are too low to
produce stable rates and are therefore excluded from
the analysis.
One approach forseparatingperiod and cohorteffects
from age patterns of incidence or mortality over time
is presented by Sacher (8,9). He proposed both a
biological-grounded model for the mortality process (8)
and a method based upon this model for separating the
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FIGURE 1. Age-standardized rates by sex for malignant melanoma
incidence and total skin cancer mortality for the United States:
(...) Connecticut male incidence; (- -) Connecticut female inci-
dence; (-) U.S. white male mortality; (--) U.S. White female
mortality. Rates computed for total skin cancer mortality and
prior to 1933 refers to the Death Registration States.
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three effects (9). Using this model as a basis for
separation of age, period, and cohort effects, Sacher
presented the expression:
Mij = Ai + Pj + Ck+ei1 (1)
where Mij is the logarithm ofthe age-specific mortality
rate for age i and calendar year j, Ai is the age
factor for the ith age level, Pj is the period factor
for the jth calendar year, Ck is the cohort factor for
the kth birth cohort, and eij is a random error term.
While the statement ofan age-period-cohort model is
straightforward, the operationalization of the function
leads to at least three major problems. These problems
are (1) what is a realistic form ofthe function, (2) what
method will be used to overcome the identification
problem and, (3) to what extent does multicollinearity
affect the solution. These problems are dealt with in
detail in other sources (10), and a full exposition is
beyond -the scope of this presentation. Results of
age-period-cohort analyses must be interpreted cau-
tiously because of inherent instability in the solution.
We proceed with this caveat in mind.
A solution for the values of the factors can be
obtained from a long-running series of age-specific
incidence rates by periods of measurement where the
interval of the ages and the periods are equal. Three
separate solutions for the age, period and cohort model
were used. The first is essentially Sacher's solution,
where the cohort effect prior to 1860 is constrainted to
zero. There is some historical evidence that this
constraint is reasonable (10). The second solution uses
the age pattern of melenoma mortality corrected for
cohort effects for Australian males and females as
presented by Holman et al. (7). This method makes the
incidence matrix of full rank and thus allows a unique
solution. This setofconstraints assumesthatAustralian
and Connecticut populations have the same age pattern
of melenoma and that there is no age difference in
survivalpatterns ofthedisease. This second assumption
may be problematic since these is evidence that relative
survivalrates formelanoma decrease with age (11). The
final solution employed a maximum eigenvalue least-
squares approach (10).
In this approach, a series of principal components is
estimated from the correlation matrix of the original
incidence matrix and the components with small
eigenvalues are eliminated. The criterionforelimination
of principal components was based upon the condition
index (12). The principal components were then trans-
lated intothe original variables toprovidethe necessary
parameter estimates.
The first solution based on historical evidence, the
second based upon a previous study and the third based
upon amathematicaldecision, yield verysimilarresults,
thus providing some support for each set ofconstraints.
Eachofthesemodelsfitthedataequallywell, explaining
95% of the variance. For the sake of brevity, only the
results of third solution will be discussed.
Results
Figure 2 presents the age pattern for the age-period-
cohort model. The pattern forboth males and females is
very similar: that is, low at age 20, increasing to a peak
at age 50, and then becoming stable. This age pattern
for melanoma has been previously documented (13). It
shouldbenotedthat the age pattern forincidence isless
steep at the older ages than the age pattern for
mortality. One possible explanation maybe the increase
in case-fatality with age (6).
The pattern forthe period effect is shown in Figure 3.
The steady increase in the period factor over time
indicates that a large part ofthe increase in incidence of
melanoma may be related to period factors. The cohort
factor is presented in Figure 4. Compared to the period
factor, there is little change over time in the cohort
factor. The cohort factor peaks around 1850 and then
drops to a low around 1900 after which there is a slight
increase to the present. This increase from 1900 to the
present corresponds with the conclusions of Houghton
(1) for the same data. In general, however, the cohort
factor displays less influence on melanoma incidence
than does the period factor.
To provide an estimation of the relative contribution
ofperiod and cohort effects, we can estimate age stan-
dardized incidence rates from the original model formu-
lation in the absence of period effects. This is done by
usingtheoriginalmodelformulationpresentedinEq. (1)
ignoring the error terms to construct the estimated
age-specific incidence rates (Mij) for age, period and
cohort factors considered simultaneously, or
Mij = Ai + Pj + Ck
and also that for age and cohort effects, or,
Mij = Ai + Ck
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FIGURE 2. Age factor by sex of the age-period-cohort model for
incidence of malignant melanoma for Connecticut.
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FIGURE 3. Period factor by sex of the age-period-cohort mod
incidence of malignant melanoma for Connecticut.
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FIGURE 4. Cohort factor by sex of the age
incidence of malignant melanoma for Cc
This latter equation, when compared to Eq. (2) will
provide a rough estimate of the contribution of period
factors to the increasing incidence of melanoma over
time.
Age standardized incidence rates (ASIR) are com-
puted from the age-specific incidence rates estimated
from Eqs. (2) and (3). The actual data is also presented.
In Table 1, the actual ASIR is 0.008286 in 1935 to 1939
and rises to 0.048759 in 1970 to 1974 or an increase of
488%. The estimated ASIR computed from the age,
period, cohort modelispresentedinthe secondequation
in Table 1. The ASIRs are slightly higher than the
actualdatabuttheincreaseisverysimilar. Equation(3),
or the estimated ASIR in the absence ofperiod effects,
shows virtually no increase in the ASIR when period
effects are ignored. Indeed, there appears to be a slight
decrease in incidence from 1935 to 1970 ifonly age and
1970 cohort factors are considered. It seems reasonable,
therefore, that explanations for the rise in incidence of
melanoma in the state of Connecticut should focus on
el for period factors.
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......... MALE There two sets of arguments that be used to
FEMALE explain the rather large period components in the inci-
dence data. First, it could be argued that the period
effect represents a real increase in the incidence of the
disease. An argument that has been made, forinstance,
is that a decrease in the ozone level in the atmosphere
_2.?-o;. ...... _ may be responsible for the increase (14). For this to be
true, however, at least for the state ofConnecticut, the
latency between exposure and appearance of the dis-
ease would have to be very short, that is 5 years or less
to produce the period effect. A longer latency in the
presence of increasing exposure would be reflected in
the age-period-cohort model as both period and cohort
effects. This results because each new birth cohort
would be exposed to higher levels ofthe environmental
1920 1940 1960 carcinogen and would thus have higher probabilities of
developing malignant melanoma than would older birth
cohorts.
-period-cohort model for A second possible explanation for the increase is that
)nnecticut. it is an artifact of how the data were collected and how
the disease was diagnosed. Incomplete registration of
Table 1. Actual and estimated age-standardized incidence rates ( x 1000) for females in Connecticut for 1935 to 1939 and 1970 to 1974.
Incidence Absolute
Equation 1935-39 1970-74 change % change
(1) Actual data 0.008286 0.048759 + 0.040473 + 488
Mij = Ai + P, + Ck + eV
(2) Estimated full model 0.008537a 0.05385 +0.045313 + 531
Mij = Ai + Pj + Ck
(3) In the absence of period effects 0.008537a 0.007275 -0.001262 -14
Mij = Ai + Ck
a The reason for the exact agreement between (2) and (3) for the time period 1935-39 is that the period effect is contained
to zero for that year in Eq. (2). This constraint does not affect the form of the function obtained.
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Table 2. Stage distribution forpatients diagnoses 1950to 1969 from
the program for cancer surveillance, epidemiology and end results
reporting (SEER).
1950-54 1955-59 1960-64 1965-69
Number classified
Localized 372 588 937 1141
Regional 120 132 163 188
Distant 120 105 177 156
Unknown 53 53 81 78
Tobtal 665 878 1358 1563
Percentage
Increase of all
classifications 32 204 235
Portion of total
increase attrib-
uted to increase
in localized 101 73 100
melanoma is probably responsible for some of period
effect even though most researchers would argue that
this effect isprobably very small (3-5). There is alsothe
possibility that improving diagnosis over time has arti-
ficially increased the incidence. Melanoma ofthe skin is
a rare tumor. More accurate diagnosis may increase the
number of tumors classified as melanoma. Early diag-
nosis may also increase incidence (15). Table 2 presents
the stage distribution by year for patients diagnosed
from the SEER Program (11). The Connecticut regis-
try represents 40% of the SEER population. The total
diagnoses for melanoma increased from 665 in 1950 to
1954 to 1563 in 1960 to 1969 representing a 235% in-
crease in the diagnosis ofthe disease. This corresponds
to the increase in incidence in Figure 1. Virtually all of
this increase appears to be related to the increase in
diagnosis of localized melanoma. These data indicate
that incidence increase in melanoma is related to an
increase in the localized stage of the disease. Earlier
diagnoses may, therefore, account for the current in-
crease in the disease. It does appearthat atleast part if
not all ofthe period effect associated with the increase
in melanoma may be attributed to an artifact ofhow the
data were collected over time.
Age-period-cohort analyses, when applied to both
incidence and mortality data, can provide important
indications of the etiology of disease under study. The
commonlycitedexplanationforincreasesinmelanomais
the change inclothingandrecreation trends since World
War II. In the present analysis, the dominance of a
period effect indicates a causative factor operating on
all age groups equally rather than one operating at an
early age, as with cohort effects.
Though sunlight is known to be animportant cause of
melanoma, research findings indicate that it is not the
only causative mechanism. Clinically, melanomas are
less concentrated in sun-exposed body sites than are
nonmelanomas. (16). Furthermore, studies in Australia
show a higher incidence for members of professional
and managerial classes living in urban areas than those
involved in outdoor work (17). The commonly proposed
hypothesis is that ofthe importance ofacute, intermit-
tent exposure to ultraviolet light rather than chronic
exposure in melanoma incidence. (13). This is particu-
larly relevant for those sex-specific sites displaying the
greatest increases in rates, that is the lower limb in
females and trunk in males, which show lack ofa strong
age dependence (1). However, it is also possible that
secularincreases in an environmental pollutant, such as
atmospheric pollution, which would accompany the
trend toward urbanization and affluence oflifestyle and
act on all age groups, are an important contributor to
the observed increased melanoma incidence. This would
also be plausible in light of the similarities of these
increases through time in both sites (18).
The cohort effect, though small, is still ofimportance.
As stated earlier, increased incidence and mortality
from melanoma have most commonly been regarded as
largely birth cohort phenomena. In the present study
the period effect dominated but the presence of cohort
effect in the incidence of malignant melanoma for the
state of Connecticut is unmistakable. However, the
effects are both fluctuating and of small magnitude.
Conclusion
Mortality and incidence formalignant melanoma have
mostoftenbeenconsidered largely acohortphenomena.
In the present study, however, incidence of melanoma
for the state of Connecticut appears to have a large
period component accounting for virtually all of the
increase in this disease over the past 35 years. While
thereis acohort component, the period component does
dominate. However, these results are based on limited
data and the etiologic implications of a period factor in
the rise in melanoma incidence, should be examined in
other data bases.
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